Pharmabiz

Concept Life Sciences appoints industry veteran Dean Bornilla as chief commercial officer to drive international expansion

Concept Life Sciences appoints industry veteran Dean Bornilla as chief commercial officer to drive international expansion: ...
Pharmabiz

PCI issues advisory to students & parents to verify approval status of institutions before admission

PCI issues advisory to students & parents to verify approval status of institutions before admission: Gireesh Babu, New Delhi Saturday, November 7, 2026, 08:00 Hrs [IST] The Pharm ...
Pharmabiz

Iksuda Therapeutics to present first clinical data for IKS03 in advanced B-cell non-Hodgkin lymphomas at American Society of Hematology

Iksuda Therapeutics to present first clinical data for IKS03 in advanced B-cell non-Hodgkin lymphomas at American Society of Hematology: Newcastle, UK Saturday, November 7, 2026, ...
Pharmabiz

Alkermes to present research data from psychiatry and sleep portfolios at Neuroscience Education Institute Fall Congress

Alkermes plc has announced its plans to present a research data from across its psychiatry and sleep medicine portfolios at the Neuroscience Education Institute (NEI) Fall Congress, which is taking ...
Pharmabiz

US FDA approves Johnson & Johnson’s Rybrevant Faspro as First and only dual-targeted therapy for advanced head and neck cancer

US FDA approves Johnson & Johnson’s Rybrevant Faspro as First and only dual-targeted therapy for advanced head and neck cancer: New Brunswick, New Jersey Saturday, November 7, 2 ...
Pharmabiz

Hutchmed’s sovleplenib receives US FDA Orphan Drug Designation for treatment of autoimmune haemolytic anaemia

Hutchmed’s sovleplenib receives US FDA Orphan Drug Designation for treatment of autoimmune haemolytic anaemia: Hong Kong, Shanghai Saturday, November 7, 2026, 14:00 Hrs [IST] Hu ...
Pharmabiz

Researchers invent new approach to treating patients with specific forms of chronic blood disorders

Researchers invent new approach to treating patients with specific forms of chronic blood disorders: Krems, Austria Saturday, November 7, 2026, 11:00 Hrs [IST] A previously unreco ...
Pharmabiz

FibroBiologics receives European patent for fibroblast delivery of tumour inhibitory agents

FibroBiologics receives European patent for fibroblast delivery of tumour inhibitory agents: Houston Saturday, November 7, 2026, 13:00 Hrs [IST] FibroBiologics Inc, a clinical-sta ...
Pharmabiz

Cold Chain Technologies raises EcoVadis status following record sustainability improvement

Cold Chain Technologies raises EcoVadis status following record sustainability improvement: United Kingdom Saturday, November 7, 2026, 15:00 Hrs [IST] Cold Chain Technologies (CCT ...
Pharmabiz

Supriya Lifescience Q2 net profit stood at Rs. 29.25 crore

In Q2 FY27, Supriya Lifescience Ltd. recorded revenue from operations of Rs. 206.30 crore, up 3.2% year-on-year from Rs. 199.83 crore in Q2 FY26. EBITDA for Q2 FY27 stood at Rs 45.40 crore, with an ...
Pharmabiz

Abbott & Novo expand strategic collaboration to launch Plosbrio broadening access to semaglutide for advanced diabetes care across Asia Pacific

Abbott & Novo expand strategic collaboration to launch Plosbrio broadening access to semaglutide for advanced diabetes care across Asia Pacific: Singapore Saturday, November 7, 20 ...
Pharmabiz

Gland Pharma Q2 net profit rises 58%

Our Bureau, Mumbai Saturday, November 7, 2026, 13:30 Hrs [IST] Gland Pharma Limited, an injectable-focused pharmaceutical company, announced ...